ASX:PME

UK & AU Stock Market Today: Live Updates 27.03.2026
·····

UK & AU Stock Market Today: Live Updates 27.03.2026

LIVEMarkets rolling coverageStarted: March 27, 2026, 12:00 AM EDTUpdated: March 27, 2026, 11:59 PM EDT 6 Key Numbers to Assess Pro Medicus Ltd (ASX:PME) Shares in 2024 March 27, 2026, 11:51 PM EDT. The Pro Medicus Ltd (ASX:PME) share price has fallen 47.13% year-to-date. Key metrics shed light on its outlook. The company, specializing in radiology IT software, posted $162 million in revenue, growing at 33.4% CAGR over three years. Its gross margin is an impressive 99.8%, reflecting core operational strength. Profit climbed from $31 million to $83 million over three years, a 39.0% CAGR. Financially, PME holds net debt
March 27, 2026

Stock Market Today

  • Nufarm Shares Rally 13% on Strong FY2026 Half-Year Results, Buy Rating Maintained
    May 27, 2026, 4:46 PM EDT. Nufarm Ltd (ASX: NUF) shares surged 13% following robust FY2026 half-year results. The company reported a 28% increase in statutory net profit after tax, rising to $38 million, and a 35% rise in underlying NPAT to $52 million. Underlying EBITDA grew 18% to $243 million, driven by improved performance in crop protection and seed technologies. Net debt fell by $135 million to $1.23 billion, reducing leverage by 20%. Broker Bell Potter maintained a buy recommendation with a $3.60 price target, citing strong earnings growth potential and ongoing cost-saving initiatives targeting $50 million for FY26. With current share prices at $2.91, the stock offers nearly 24% upside, trading at a 25% discount to global peers. Management reaffirmed FY26 outlook, anticipating continued earnings growth and leverage reduction.